Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-138365
Filing Date
2023-05-08
Accepted
2023-05-08 17:02:16
Documents
9
Effectiveness Date
2023-05-08

Document Format Files

Seq Description Document Type Size
1 S-3ASR d481003ds3asr.htm S-3ASR 369247
2 EX-1.2 d481003dex12.htm EX-1.2 170925
3 EX-5.1 d481003dex51.htm EX-5.1 22475
4 EX-23.1 d481003dex231.htm EX-23.1 1737
5 EX-FILING FEES d481003dexfilingfees.htm EX-FILING FEES 42073
6 GRAPHIC g481003g04p35.jpg GRAPHIC 33406
7 GRAPHIC g481003g0505080001999.jpg GRAPHIC 3252
8 GRAPHIC g481003g0505080002124.jpg GRAPHIC 1414
9 GRAPHIC g481003g32p50.jpg GRAPHIC 20171
  Complete submission text file 0001193125-23-138365.txt   688322
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-271731 | Film No.: 23898694
SIC: 2836 Biological Products, (No Diagnostic Substances)